Role of HHV-8 in Kaposi sarcoma - Abstract and commentary

被引:4
|
作者
Schmid, DS [1 ]
机构
[1] Ctr Dis Control & Prevent, Viral Immunol Sect, Atlanta, GA 30333 USA
来源
关键词
D O I
10.1001/jama.280.6.570
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although human herpesvirus 8 (HHV-8) has been suspected to be the etiologic agent of Kaposi's sarcoma, little is known about its seroprevalence in the population, its modes of transmission, and its natural history. Methods: The San Francisco Men's Health Study, begun in 1984, is a study of a population-based sample of men in an area with a high incidence of human immunodeficiency virus (HIV) infection. We studied all 400 men infected at base line with HIV and a sample of 400 uninfected men. Base-line serum samples were assayed for antibodies to HHV-8 latency-associated nuclear antigen (anti-LANA). In addition to the seroprevalence and risk factors for anti-LANA seropositivity, we analyzed the time to the development of Kaposi's sarcoma. Results: Anti-LANA antibodies were found in 223 of 593 men (37.6 percent) who reported any homosexual activity in the previous five years and in none of 195 exclusively heterosexual men. Anti-LANA seropositivity correlated with a history of sexually transmitted diseases and had a linear association with the number of male sexual-intercourse partners. Among the men who were infected with both HIV and HHV-8 at base line, the 10-year probability of Kaposi's sarcoma was 49.6 percent. Base-line anti-LANA seropositivity preceded and was independently associated with subsequent Kaposi's sarcoma, even after adjustment for CD4 cell counts and the number of homosexual partners. Conclusions: The prevalence of HHV-8 infection is high among homosexual men, correlates with the number of homosexual partners, and is temporally and independently associated with Kaposi's sarcoma. These observations are further evidence that HHV-8 has an etiologic role in Kaposi's sarcoma and is sexually transmitted among men.
引用
收藏
页码:570 / 571
页数:2
相关论文
共 50 条
  • [1] The role of HHV-8 in Kaposi's sarcoma
    Neipel, F
    Fleckenstein, B
    [J]. SEMINARS IN CANCER BIOLOGY, 1999, 9 (03) : 151 - 164
  • [2] Role of HHV-8 in the pathogenesis of Kaposi's sarcoma
    Ensoli, B
    Monini, P
    Colombini, S
    Goletti, D
    Cafaro, A
    Buttò, S
    Sgadari, C
    Leone, P
    Franco, M
    Leone, P
    Stürzl, M
    Verani, P
    [J]. HAEMATOLOGICA, 1998, 83 (05) : 467 - 468
  • [3] Kaposi's sarcoma and HHV-8
    Offermann, MK
    [J]. TRENDS IN MICROBIOLOGY, 1996, 4 (11) : 419 - 419
  • [4] Reactivation and role of HHV-8 in Kaposi's sarcoma initiation
    Ensoli, B
    Stürzl, M
    Monini, P
    [J]. ADVANCES IN CANCER RESEARCH, VOL 81, 2001, 81 : 161 - 200
  • [5] HHV-8 serology and Kaposi's sarcoma
    Gompels, UA
    Kasolo, FC
    [J]. LANCET, 1996, 348 (9041): : 1587 - 1588
  • [6] Human herpesvirus 8 (HHV-8) and Kaposi sarcoma
    Lebbe, C.
    [J]. HAUTARZT, 2008, 59 (01): : 18 - 25
  • [7] Humanes herpesvirus 8 (HHV-8) and Kaposi sarcoma [Humanes herpesvirus 8 (HHV-8) und Kaposi-sarkom]
    Lebbé C.
    [J]. Der Hautarzt, 2008, 59 (1): : 18 - 25
  • [8] HHV-8 in PBMC and Kaposi's sarcoma activity
    Poggi, C
    Lafeuillade, A
    Profizi, N
    PoizotMartin, I
    [J]. INFECTION, 1997, 25 (05) : 326 - 326
  • [9] HHV-8 associated Kaposi sarcoma -: Case report
    Sahin, Gurses
    Ertem, Ulya
    Yuksek, Nazmiye
    Plancoulaine, Sabine
    Casanova, Jean-Laurent
    Akbay, C. G.
    Ozkaya, O.
    Bozkur, Ceyhun
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 473 - 473
  • [10] Kaposi's sarcoma and HHV-8: Implications for therapy
    Lin, JC
    [J]. INFECTIONS IN MEDICINE, 1998, 15 (05) : 337 - 343